October 4, 2021 at 3pm BST | 10am EST | 4pm CEST Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.
Register Free: http://www.chromatographyonline.com/lcgc_w/gmp
Join global industry and regulatory experts as they discuss current extractables and leachables (E&L) hot topics on pharmaceuticals, biopharmaceuticals, and medical devices. Extractables and leachables are an important consideration when developing medical products and devices. This conference will give you an insight into a number of different topics within the ever-changing world of E&L.
Key Learning Objectives:
Who Should Attend:
ISO 10993-18: Establishing an AET for Chemical Characterization of Medical Devices
Ted Heise, PhD, RAC – MED Institute, Managing Partner &Toxicologist, D&B ChemTox, LLC
E&L in Biological Combination Products
Alicja Sobantka, PhD, Material Qualification, Octapharma
Managing Change in This Rapidly Changing World of Extractables and Leachables
Nick Morley, Principal Scientist, Hall Analytical
Strategies to Overcome Challenges in Extractable Screening Studies
Rachel Sanig, Senior Scientist, Waters Corporation
What is the Future of Leachables and Extractables Assessment?
Dan Norwood, Principal Consultant, Feinberg Norwood & Associates Pharma Consulting
What next for E&L?- Data, Information, Knowledge to Wisdom
Jason Creasey, Managing Director, Maven E&L Ltd
Qualification of screening methods, how is this achieved?
European E&L Strategic Director
Ted Heise, PhD
RAC – MED Institute, Managing Partner & Toxicologist
D&B ChemTox, LLC
Alicja Sobantka, PhD
Feinberg Norwood & Associates Pharma Consulting
Maven E&L Ltd
Register Free: http://www.chromatographyonline.com/lcgc_w/Hall_Part3